Press release
Intracranial Hemorrhage Pipeline Dynamics 2024: FDA Approvals,Therapeutic Advances by DelveInsight | Invamed, Medtronic, Stryker, Penumbra, MicroPort Scientific, Siemens, ClearMind Biomedical, Acandis
The Intracranial Hemorrhage Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
"Intracranial Hemorrhage Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/intracranial-hemorrhage-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Intracranial Hemorrhage Market.
Some of the key takeaways from the Intracranial Hemorrhage Pipeline Report:
*
Companies across the globe are diligently working toward developing novel Intracranial Hemorrhage treatment therapies with a considerable amount of success over the years.
*
Intracranial Hemorrhage companies working in the treatment market are Cenyx Biotech, BIT Pharma, Bioxodes, Novo Nordisk, Assistance Publique, Bioxodes S.A., Aaron Cook, Acasti Pharma Inc., Basking Biosciences, Hope Biosciences, and others, are developing therapies for the Intracranial Hemorrhage treatment
*
Emerging Intracranial Hemorrhage therapies in the different phases of clinical trials are- CX213, Nicardipine, Ir-CPI, rFVIIa, Levosimendan, Ir-CPI, Telavancin Injection, GTX-104, BB-031, Autologous HB-adMSCs, and others are expected to have a significant impact on the Intracranial Hemorrhage market in the coming years.
*
In October 2023, Acasti Pharma Inc. announced it held a virtual Key Opinion Leader (KOL) event focused on GTX-104, highlighting its potential as a new treatment standard for rare and life-threatening aneurysmal subarachnoid hemorrhage (aSAH).
*
In September 2023, Acasti Pharma Inc. announced the completion of a private placement of its securities under a Purchase Agreement dated September 24, 2023, involving institutional and accredited investors.
Intracranial Hemorrhage Overview
Intracranial hemorrhage (ICH) refers to bleeding that occurs inside the skull, specifically within the brain or the surrounding membranes (meninges). This condition is a medical emergency because the buildup of blood can increase pressure on the brain, potentially leading to neurological damage or even death. Intracranial hemorrhage can result from various causes, including head trauma, high blood pressure (hypertension), aneurysms, arteriovenous malformations (AVMs), hemorrhagic stroke, blood clotting disorders, or the use of anticoagulant medications.
Get a Free Sample PDF Report to know more about Intracranial Hemorrhage Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/intracranial-hemorrhage-pipeline-insight [https://www.delveinsight.com/report-store/intracranial-hemorrhage-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Emerging Intracranial Hemorrhage Drugs Under Different Phases of Clinical Development Include:
*
CX213: Cenyx Biotech
*
Nicardipine: BIT Pharma
*
Ir-CPI: Bioxodes
*
rFVIIa: Novo Nordisk
*
Levosimendan: Assistance Publique - Hopitaux de Paris
*
Ir-CPI: Bioxodes S.A.
*
Telavancin Injection: Aaron Cook
*
GTX-104: Acasti Pharma Inc.
*
BB-031: Basking Biosciences
*
Autologous HB-adMSCs: Hope Biosciences
Intracranial Hemorrhage Route of Administration
Intracranial Hemorrhage pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
*
Oral
*
Parenteral
*
Intravenous
*
Subcutaneous
*
Topical
Intracranial Hemorrhage Molecule Type
Intracranial Hemorrhage Products have been categorized under various Molecule types, such as
*
Monoclonal Antibody
*
Peptides
*
Polymer
*
Small molecule
*
Gene therapy
Intracranial Hemorrhage Pipeline Therapeutics Assessment
*
Intracranial Hemorrhage Assessment by Product Type
*
Intracranial Hemorrhage By Stage and Product Type
*
Intracranial Hemorrhage Assessment by Route of Administration
*
Intracranial Hemorrhage By Stage and Route of Administration
*
Intracranial Hemorrhage Assessment by Molecule Type
*
Intracranial Hemorrhage by Stage and Molecule Type
DelveInsight's Intracranial Hemorrhage Report covers around 10+ products under different phases of clinical development like
*
Late-stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I)
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
*
Route of Administration
Further Intracranial Hemorrhage product details are provided in the report. Download the Intracranial Hemorrhage pipeline report to learn more about the emerging Intracranial Hemorrhage therapies [https://www.delveinsight.com/sample-request/intracranial-hemorrhage-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key companies in the Intracranial Hemorrhage Therapeutics Market include:
Key companies developing therapies for Intracranial Hemorrhage are - Medtronic, Stryker, Penumbra, Inc., MicroPort Scientific Corporation, Siemens Healthcare GmbH, ClearMind Biomedical Inc., Acandis GmbH, Cerenovus (Johnson & Johnson Services, Inc.), Invamed, General Electric Company, InfraScan, Inc., MicroVention Inc. (Terumo Corporation), adeor medical AG, Kaneka Medix Corporation, B. Braun Melsungen AG, SCHINDLER Endoskopie Technologie, CANON MEDICAL SYSTEMS CORPORATION, Hyperfine, phenox GmbH, Perflow Medical Ltd., and others.
Intracranial Hemorrhage Pipeline Analysis:
The Intracranial Hemorrhage pipeline report provides insights into
*
The report provides detailed insights about companies that are developing therapies for the treatment of Intracranial Hemorrhage with aggregate therapies developed by each company for the same.
*
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Intracranial Hemorrhage Treatment.
*
Intracranial Hemorrhage key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
Intracranial Hemorrhage Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Intracranial Hemorrhage market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Intracranial Hemorrhage drugs and therapies [https://www.delveinsight.com/sample-request/intracranial-hemorrhage-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Intracranial Hemorrhage Pipeline Market Drivers
*
Increasing Incidence of intracranial hemorrhage, Technological and Medical Research Advancement, are some of the important factors that are fueling the Intracranial Hemorrhage Market.
Intracranial Hemorrhage Pipeline Market Barriers
*
However, Strict Approval Procedures for Regulations, High Development Costs, and other factors are creating obstacles in the Intracranial Hemorrhage Market growth.
Scope of Intracranial Hemorrhage Pipeline Drug Insight
*
Coverage: Global
*
Key Intracranial Hemorrhage Companies: Cenyx Biotech, BIT Pharma, Bioxodes, Novo Nordisk, Assistance Publique, Bioxodes S.A., Aaron Cook, Acasti Pharma Inc., Basking Biosciences, Hope Biosciences, and others
*
Key Intracranial Hemorrhage Therapies: CX213, Nicardipine, Ir-CPI, rFVIIa, Levosimendan, Ir-CPI, Telavancin Injection, GTX-104, BB-031, Autologous HB-adMSCs, and others
*
Intracranial Hemorrhage Therapeutic Assessment: Intracranial Hemorrhage current marketed and Intracranial Hemorrhage emerging therapies
*
Intracranial Hemorrhage Market Dynamics: Intracranial Hemorrhage market drivers and Intracranial Hemorrhage market barriers
Request for Sample PDF Report for Intracranial Hemorrhage Pipeline Assessment and clinical trials [https://www.delveinsight.com/sample-request/intracranial-hemorrhage-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Intracranial Hemorrhage Report Introduction
2. Intracranial Hemorrhage Executive Summary
3. Intracranial Hemorrhage Overview
4. Intracranial Hemorrhage- Analytical Perspective In-depth Commercial Assessment
5. Intracranial Hemorrhage Pipeline Therapeutics
6. Intracranial Hemorrhage Late Stage Products (Phase II/III)
7. Intracranial Hemorrhage Mid Stage Products (Phase II)
8. Intracranial Hemorrhage Early Stage Products (Phase I)
9. Intracranial Hemorrhage Preclinical Stage Products
10. Intracranial Hemorrhage Therapeutics Assessment
11. Intracranial Hemorrhage Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Intracranial Hemorrhage Key Companies
14. Intracranial Hemorrhage Key Products
15. Intracranial Hemorrhage Unmet Needs
16 . Intracranial Hemorrhage Market Drivers and Barriers
17. Intracranial Hemorrhage Future Perspectives and Conclusion
18. Intracranial Hemorrhage Analyst Views
19. Appendix
20. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=intracranial-hemorrhage-pipeline-dynamics-2024-fda-approvalstherapeutic-advances-by-delveinsight-invamed-medtronic-stryker-penumbra-microport-scientific-siemens-clearmind-biomedical-acandis]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intracranial Hemorrhage Pipeline Dynamics 2024: FDA Approvals,Therapeutic Advances by DelveInsight | Invamed, Medtronic, Stryker, Penumbra, MicroPort Scientific, Siemens, ClearMind Biomedical, Acandis here
News-ID: 3551453 • Views: …
More Releases from ABNewswire
Understanding Magnetic Switches: Types, Working Principles, and Applications
A magnetic switch is a versatile electrical device that operates by responding to magnetic fields. From Hall Effect to reed switches, explore their functions, types, and diverse applications.
What is a Magnetic Switch?
A magnetic switch is an electrical device that operates by responding to the presence of a magnetic field. It functions by closing or opening its contacts based on the strength of the magnetic field. Specifically, the switch remains closed…
Innovating embedded downlight technology: Leading the global trend of intelligen …
The strong rise of China's manufacturing industry has profoundly reshaped the technological landscape and development trajectory of embedded downlights. With its unparalleled industrial chain advantages, continuous technological innovation, and significant cost-effectiveness, Chinese enterprises have risen from participants in the global lighting industry to undisputed leaders. This transformation goes far beyond the huge production scale; it lies in the thorough innovation of the core technical content and application boundaries of embedded…
North China Electric Power University Foreign Aid Training Program Visits Yiyuan …
On July 23, 2025, the Electrical Industry Training Program of North China Electric Power University's Foreign Aid Project visited Yiyuan Technology for an exchange visit. The purpose was to gain in-depth insights into the company's innovations in renewable energy technology promotion and application [https://www.yiyen.com/about/], and to build bridges connecting university-enterprise cooperation with foreign aid initiatives.
Image: https://ecdn6.globalso.com/upload/p/1108/image_other/2025-07/scene-1.jpg
Image: https://ecdn6.globalso.com/upload/p/1108/image_other/2025-07/scene-3.jpg
Upon arrival, the delegation received a warm welcome from company leadership and the reception…
Pure Sine Wave Low Frequency Inverter Charger
Pure sine wave low frequency inverter [https://www.yiypower.com/ap-mini-600w-1500w-120v-low-frequency-pure-sine-wave-inverter-charger-product/] is widely used and suitable for a variety of scenarios. In terms of home backup power, it can provide reliable power during power outages, ensuring that essential appliances such as refrigerators, air conditioners and medical equipment continue to operate . For solar power generation systems, Inverter charger [https://www.yiypower.com/ap-mini-600w-1500w-120v-low-frequency-pure-sine-wave-inverter-charger-product/] can converter DC Power from Battery, which charged by solar panels, into clean alternating current…
More Releases for Intracranial
Intracranial Pressure Monitoring Devices Market: "Intracranial Pressure Monitori …
Intracranial Pressure Monitoring Devices Market Scope:
Key Insights : Intracranial Pressure Monitoring Devices Market size was valued at USD 1.60 Billion in 2022 and is poised to grow from USD 1.72 Billion in 2023 to USD 3.15 Billion by 2031, at a CAGR of 7.80% during the forecast period (2024-2031).
Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/intracranial-pressure-monitoring-devices-market
In-Depth Exploration of the global Intracranial Pressure Monitoring Devices Market:…
Intracranial Aneurysm Market Report 2030
Intracranial aneurysms, silent yet perilous anomalies in cerebral blood vessels, present a pressing healthcare concern. With the market poised to surge from USD 1.2 billion in 2021 to USD 2.6 billion by 2030, fueled by escalating incidences and groundbreaking product introductions, addressing this medical challenge becomes imperative.
Download Sample Report Copy Of This Report From Here: https://www.amecoresearch.com/sample/276712
Key Points and Statistics:
• The Intracranial Aneurysm Market is forecasted to reach USD 2.63 billion…
Intracranial Stenosis Stents Market Analysis 2023 - Focus on Intracranial Stenos …
The Intracranial Stenosis Stents Market is witnessing steady growth as the demand for innovative neurointerventional devices to treat intracranial arterial stenosis continues to rise. Intracranial stenosis, the narrowing of blood vessels within the brain, poses a significant risk of stroke and other serious neurological complications. Stents designed specifically for intracranial use have become a crucial tool for neurosurgeons and interventional radiologists in managing these conditions. These stents help to open…
Intracranial Aneurysm Market Size & Share Report, 2031
global Intracranial Aneurysm market in the year 2012 is valued at 1.15 billion and is predicted to reach 2.50 billion by the year 2031 at an 9.2% CAGR during the forecast period.
Get a Free Sample Report: https://www.insightaceanalytic.com/request-sample/1283
An abnormal focal expansion of an artery caused by a weakening of the blood vessel wall's inner muscle layer (the intima) is known as a cerebral or intracranial aneurysm. The rise in the number of risk…
Intracranial Pressure Monitors Market : Growing Prevalence of Traumatic Injuries …
The international intracranial pressure monitors market is experiencing a shift to non-invasive ones from invasive devices, as demands of patients have changed, says Transparency Market Research (TMR) in its latest market research report. Manufacturers of intracranial pressure monitors within this industry are facing stiff competition and this is further compelling them to stay up dated offering their customers with the latest of all devices. Thus, much of the emphasis is…
Intracranial Pressure Monitors Market : Growing Prevalence of Traumatic Injuries …
The international intracranial pressure monitors market is experiencing a shift to non-invasive ones from invasive devices, as demands of patients have changed, says Transparency Market Research (TMR) in its latest market research report. Manufacturers of intracranial pressure monitors within this industry are facing stiff competition and this is further compelling them to stay up dated offering their customers with the latest of all devices. Thus, much of the emphasis is…
